'%3e%3cpath%20d='M34.1406%205.85938C30.3906%202.10547%2025.3047%200%2020%200C14.6953%200%209.60938%202.10547%205.85938%205.85938C2.10938%209.61328%200%2014.6953%200%2020C0%2025.3047%202.10547%2030.3906%205.85938%2034.1406C9.61328%2037.8906%2014.6953%2040%2020%2040C25.3047%2040%2030.3906%2037.8945%2034.1406%2034.1406C37.8906%2030.3906%2040%2025.3047%2040%2020C40%2014.6953%2037.8945%209.60938%2034.1406%205.85938ZM37.0117%2023.543H31.1602V13.5391H27.6328V19.9414C28.1211%2020.6914%2028.3711%2021.582%2028.3711%2022.5625V22.625C28.3711%2023.668%2028.1172%2024.6055%2027.6328%2025.4297V26.6094H36.082C33.4883%2032.9375%2027.2891%2037.3789%2020.0039%2037.3789C10.3711%2037.3789%202.62109%2029.6289%202.62109%2020C2.62109%2010.3711%2010.3711%202.62109%2020%202.62109C29.6289%202.62109%2037.3789%2010.3711%2037.3789%2020C37.3789%2021.1484%2037.2617%2022.2656%2037.0508%2023.3477C37.0391%2023.4141%2037.0234%2023.4766%2037.0117%2023.543Z'%20fill='white'/%3e%3cpath%20d='M22.3086%2018.5352C20.4336%2018.125%2019.9531%2017.8398%2019.9766%2017.1836V17.1406C19.9766%2016.6992%2020.3477%2016.2148%2021.4023%2016.2148C22.582%2016.2148%2023.8867%2016.6797%2025.0781%2017.4766L26.8516%2015.0195C25.4453%2013.8906%2023.707%2013.3398%2021.5547%2013.3398C18.5195%2013.3398%2016.4375%2015%2016.4063%2017.4766V17.5352C16.3633%2020.2617%2018.5859%2020.9805%2021.293%2021.6016C23.0391%2021.9766%2023.5703%2022.3164%2023.5703%2022.9609L23.5469%2022.9766C23.5469%2023.3906%2023.2578%2023.7031%2022.7852%2023.8359C22.5742%2023.9062%2022.1289%2023.9727%2021.5156%2023.9727C20.7617%2023.9727%2019.7539%2023.8633%2018.6328%2023.4844C18.0898%2023.2891%2017.4727%2023.0039%2016.8047%2022.6133L20.1406%2026.625C20.2813%2026.6602%2021.0977%2026.8516%2021.7734%2026.8516C25.0039%2026.8516%2027.0859%2025.2461%2027.1094%2022.6328V22.5703C27.1602%2020.1133%2025.2148%2019.1719%2022.3086%2018.5352Z'%20fill='white'/%3e%3cpath%20d='M5.24219%2013.5664V26.6133H8.75391V23.7578L10.2969%2021.9531L14.2031%2026.6133H18.3867L12.3555%2019.5195L17.4023%2013.5664H13.4531L8.75391%2019.0586V13.5664H5.24219Z'%20fill='white'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_97_2430'%3e%3crect%20width='40'%20height='40'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
Lifestyle Features
Most Recent
Kenya reports third Ebola case, a close relative of first two patients
Reuters | Updated Oct. 16 - 10:44 a.m. | Save Story
Kenya reported its third Ebola infection on Friday, in a woman it said was closely related to the first two patients.
Eli Lilly's weight-loss pill wins EU drug regulator's backing
Sriparna Roy, Reuters | Updated Oct. 16 - 9:30 a.m. | Save Story
The European Medicines Agency's committee on Friday recommended approval of Eli Lilly's weight-loss pill Foundayo, the second oral obesity drug to win the agency's backing after Novo Nordisk's Wegovy pill.
FDA flags Edwards heart-valve delivery system issue after death, injury
Reuters | Updated Oct. 16 - 8:56 a.m. | Save Story
The US FDA on Thursday warned of a potentially high-risk issue involving certain Edwards Lifesciences delivery systems used in transcatheter mitral valve replacement after one death and one serious injury.
AstraZeneca strikes $40 million AI drug discovery deal with insitro
Patrick Wingrove, Reuters | Updated Oct. 15 - 4:54 p.m. | Save Story
AstraZeneca has teamed up with artificial intelligence biotech company insitro to discover and develop new treatments for difficult to treat liver and heart conditions, the British drugmaker said on Thursday.
Congo Ebola outbreak spreads to new province bordering Central African Republic
Reuters | Updated Oct. 15 - 3:12 p.m. | Save Story
The ongoing Ebola outbreak in Democratic Republic of Congo has spread to a new province bordering Central African Republic, two health officials said on Thursday, posing a fresh challenge for authorities struggling to contain it.
Kimberly-Clark posts preliminary results above estimates, China clears formamide claims
Reuters | Updated Oct. 15 - 9:28 a.m. | Save Story
Kimberly-Clark on Thursday reported preliminary third-quarter sales and profit above expectations on the back of steady demand and cost-saving measures.
Revolution Medicines wins EU committee backing for pancreatic cancer treatment
Reuters | Updated Oct. 15 - 8:59 a.m. | Save Story
A European Medicines Agency committee on Thursday recommended EU approval of Revolution Medicines' drug for adults with metastatic pancreatic cancer, potentially offering patients in the bloc a new option for a disease with limited effective therapies.
Utah women are reshaping the state's publishing industry one costumed fan event at a time
VideoBrenna Donnelly, KSL | Updated Oct. 15 - 7:12 a.m. | Save Story
Female authors are growing in number and popularity, in part due to off-page social events created by fans.
Human cases of West Nile virus rise in Europe, with 141 dead in 2026, report says
Margaux Perrin, Reuters | Posted Oct. 15 - 7:02 a.m. | Save Story
The European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) said on Thursday that as of early October, 18 European countries had reported 1,855 people being infected by the West Nile virus since the beginning of 2026, including 141 deaths.
Prince Harry and wife Meghan make first joint appearance since UK return
VideoHannah McKay and Vitalii Yalahuzian, Reuters | Updated Oct. 15 - 6:59 a.m. | Save Story
Prince Harry and his wife Meghan appeared together in public on Thursday for the first time since they made a surprise return to Britain.
The first new sunscreen type in 25 years has arrived on store shelves
Matthew Perrone, Associated Press | Updated Oct. 14 - 4:48 p.m. | Save Story
Americans have a new sunscreen option for the first time in over 25 years after the FDA approved the chemical BEMT back in June, which offers broad protection without the cosmetic downsides.
Pennsylvania reports 1,222 measles cases as outbreak grows
Reuters | Posted Oct. 14 - 11:30 a.m. | Save Story
The Pennsylvania Health Department on Wednesday reported 1,222 measles cases in the state, up 86 cases from a week earlier.
GSK plans to cut up to 1,217 jobs in Belgium as it begins three-year restructuring plan
Reuters | Updated Oct. 14 - 10:28 a.m. | Save Story
GSK said on Wednesday it could cut as many as 1,217 jobs in Belgium, in the first sign that the British drugmaker's three-year plan to save £1.9 billion ($2.50 billion) in costs is moving into action.
Galderma to buy US firm ZO Skin Health for $1.5 billion
Reuters | Updated Oct. 14 - 10:08 a.m. | Save Story
Swiss skincare firm Galderma has agreed to acquire US company ZO Skin Health for an enterprise value of $1.5 billion, it said on Wednesday, confirming a report published by Reuters earlier in the day.
Vir, Gilead team up on solid tumor cancer therapies in up to $1.9 billion deal
Reuters | Updated Oct. 14 - 7:57 a.m. | Save Story
Vir Biotechnology said on Wednesday it had signed a collaboration agreement worth up to $1.88 billion with Gilead Sciences to discover and develop new cancer treatments for solid tumors.
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion
Reuters | Updated Oct. 14 - 7:55 a.m. | Save Story
Danish obesity-drug developer Zealand Pharma has partnered with US biotechnology company Generate Biomedicines to develop protein-based treatments for obesity and other metabolic diseases using AI, in a deal worth up to $1.2 billion.
As Ebola spreads in eastern Congo, mothers and children shun vital care
Gradel Muyisa Mumbere and Clement Bonnerot, Reuters | Updated Oct. 14 - 3:13 a.m. | Save Story
The fear of Ebola is keeping women and children from seeking healthcare in eastern Congo, health workers and aid agencies say, contributing to soaring maternal deaths and falling childhood immunization rates that could strain the healthcare system for years to come.
Lonza sets new mid-term targets, confirms 2026 outlook
Reuters | Posted Oct. 13 - 11:34 p.m. | Save Story
Swiss contract drug manufacturer Lonza set new mid-term targets and confirmed its 2026 outlook on Wednesday ahead of its capital markets day, while saying third-quarter performance was in line with expectations across its business areas.
